Its net profit declined 10.8% to ₹52 crore in the second quarter compared to ₹58.3 crore in the same period last year.
The company's revenue was down 20.6% at ₹165.4 crore from ₹208.2 crore it reported in the September quarter last year.
Its earnings before interest, taxes, depreciation and amortisation (EBITDA) declined 21% to ₹55 crore in the September quarter from ₹69.4 crore last year.
Its margin contracted marginally to 33.1% from 33.3% in the year-ago period.
Blue Jet Healthcare, which listed in 2023, manufactures specialty pharmaceutical and healthcare ingredients used in contrast media, high-intensity sweeteners and regulated markets.
The stock was down 9.54% at ₹609.75 apiece around 1.10 pm on Tuesday.
Also Read: Snowman Logistics shares drop 5% after net loss in Q2, revenue rises 8.5%
/images/ppid_59c68470-image-176224507316572693.webp)










